Impact of conditioning regimen on outcome of 2-year disease-free survivors of autologous stem cell transplantation (ASCT) for Hodgkin lymphoma (HL).
B. M. William
No relevant relationships to disclose
F. R. Loberiza
No relevant relationships to disclose
V. Whalen
No relevant relationships to disclose
P. J. Bierman
No relevant relationships to disclose
G. Bociek
No relevant relationships to disclose
J. Vose
Research Funding - Allos Therapeutics; Astellas Pharma; Bristol-Myers Squibb; Celgene; Genentech; GlaxoSmithKline; Millennium; Novartis; Pharmacyclics; Rigel
J. O. Armitage
Consultant or Advisory Role - Biogen Idec; Eisai; Seattle Genetics; ZIOPHARM Oncology